Halxim-O Tablet is a combination antibiotic formulation containing Cefixime 200 mg and Ofloxacin 200 mg, designed for the treatment of a broad spectrum of bacterial infections. Cefixime, a third-generation cephalosporin, exerts its bactericidal action by inhibiting bacterial cell wall synthesis, leading to cell lysis and death. Ofloxacin, a fluoroquinolone antibiotic, inhibits bacterial DNA gyrase and topoisomerase IV, enzymes essential for DNA replication and transcription, thereby preventing bacterial proliferation. This synergistic combination enhances antimicrobial efficacy against both Gram-positive and Gram-negative pathogens, including strains resistant to monotherapy. Halxim-O is indicated for the treatment of respiratory tract infections, urinary tract infections, otitis media, skin and soft tissue infections, and gonorrhea caused by susceptible organisms. The tablet should be administered orally as prescribed by a healthcare professional, with dosage adjustments based on infection severity and patient renal function. Caution is advised in patients with a history of hypersensitivity to cephalosporins, fluoroquinolones, or any component of the formulation. Potential side effects include gastrointestinal disturbances, hypersensitivity reactions, and, rarely, tendonitis or tendon rupture associated with fluoroquinolones. Halxim-O should be used under strict medical supervision to minimize resistance development and ensure optimal therapeutic outcomes.